Respiratory news

Pressurised metered dose inhalers: MHRA warns of cap inhalation risk

Pressurised metered dose inhalers: MHRA warns of cap inhalation risk

Reports of inhaler mouthpiece covers being accidentally...

One week of steroids 'as effective as two weeks' for severe COPD

One week of steroids 'as effective as two weeks' for severe COPD

A shorter course of steroids lasting 3 to 7 days appears...

New salmeterol/fluticasone inhaler for adult and childhood asthma

New salmeterol/fluticasone inhaler for adult and childhood asthma

The new pressurised metered-dose inhaler (MDI) Combisal...

Long-acting anticholinergic licensed for childhood asthma

Long-acting anticholinergic licensed for childhood asthma

Spiriva Respimat (tiotropium) is now licensed for use...

MIMS Respiratory and Allergy Learning workshops 2018 - new Glasgow date announced

MIMS Respiratory and Allergy Learning workshops 2018 - new Glasgow date announced

A free full-day MIMS workshop in Glasgow has just been...

Capsule inhalation warning for tiotropium inhaler

Capsule inhalation warning for tiotropium inhaler

Train patients prescribed Braltus (tiotropium) in the...

MIMS Respiratory and Allergy Learning workshops 2018 - new Liverpool date announced

MIMS Respiratory and Allergy Learning workshops 2018 - new Liverpool date announced

A free full-day MIMS workshop in Liverpool has just...

Three-quarters of COPD cases linked to childhood risk factors

Three-quarters of COPD cases linked to childhood risk factors

Chronic obstructive pulmonary disease (COPD) frequently...

SMART therapy linked to better asthma outcomes

SMART therapy linked to better asthma outcomes

Single maintenance and reliever therapy (SMART) is...

Increasing inhaled steroid doses may not prevent asthma exacerbations in children

Increasing inhaled steroid doses may not prevent asthma exacerbations in children

Children with mild to moderate asthma do not benefit...

MIMS Respiratory and Allergy Learning workshops 2018 - new Birmingham date announced

MIMS Respiratory and Allergy Learning workshops 2018 - new Birmingham date announced

A free full-day MIMS workshop in Birmingham has just...

New biologic for severe eosinophilic asthma

New biologic for severe eosinophilic asthma

Benralizumab (Fasenra) is the latest biologic to be...

Quadrupling steroid dose reduces risk of asthma exacerbations

Quadrupling steroid dose reduces risk of asthma exacerbations

Temporarily increasing the inhaled glucocorticoid dose...

New MIMS workshop announced launching the 2018 'Respiratory and Allergy Learning Series'

New MIMS workshop announced launching the 2018 'Respiratory and Allergy Learning Series'

A free full-day MIMS workshop has just been launched...

New once-daily triple combination inhaler for COPD

New once-daily triple combination inhaler for COPD

Trelegy Ellipta is the second 3-in-1 treatment for...

First NICE asthma guideline recommends oral treatment before LABA

First NICE asthma guideline recommends oral treatment before LABA

NICE suggests offering a leukotriene receptor antagonist...

Combined LABA/steroid inhaler added to Easyhaler range

Combined LABA/steroid inhaler added to Easyhaler range

Fobumix Easyhaler 320/9 (budesonide/formoterol) is...

New salmeterol/fluticasone MDI extends choice in asthma prescribing

New salmeterol/fluticasone MDI extends choice in asthma prescribing

Aloflute (salmeterol/fluticasone) metered dose inhaler...

NICE approves reslizumab for severe eosinophilic asthma

NICE approves reslizumab for severe eosinophilic asthma

NICE has approved the use of reslizumab (Cinqaero)...

First triple combination inhaler launched for COPD

First triple combination inhaler launched for COPD

Trimbow is a 3-in-1 treatment for chronic obstructive...

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more